Liothymed T3 Driada Medical

£25.00

Liothyronine Sodium (T3) by Driada Medical represents a synthetic thyroid hormone compound extensively researched for metabolic rate modulation and cellular energy regulation studies in laboratory settings.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Liothymed T3 Driada Medical
Liothymed T3 Driada Medical
£25.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Liothymed T3 Driada Medical — Research Summary

Liothyronine Sodium is a synthetic form of triiodothyronine (T3), the most metabolically active thyroid hormone in the human endocrine system. This compound by Driada Medical provides researchers with a standardised preparation for investigating thyroid hormone receptor pathways and metabolic regulation mechanisms. T3 demonstrates significantly higher biological activity compared to thyroxine (T4), making it particularly valuable for studies examining acute metabolic responses and cellular energy expenditure. Research applications span from basic endocrinology studies to advanced investigations of mitochondrial function and thermogenesis regulation. The compound’s rapid onset of action in laboratory models makes it ideal for time-sensitive metabolic research protocols.

Metabolic Research Applications

Researchers at Stroid UK Shop investigate Liothyronine Sodium for its effects on basal metabolic rate, protein synthesis, and lipolytic pathways. Studies examine its interaction with thyroid hormone receptors (TRα and TRβ) and subsequent gene expression changes affecting metabolic enzymes. The compound is particularly valuable in metabolic research investigating thermogenesis, mitochondrial biogenesis, and cellular energy utilisation. Research models utilise this compound to study thyroid hormone resistance conditions and metabolic dysfunction scenarios. Laboratory investigations also examine its synergistic effects with other compounds available in selective androgen receptor modulator research and peptide hormone studies. Current research explores optimal dosing protocols for various experimental models and tissue-specific responses to T3 administration.

Technical Specifications

Product Specifications – Driada Medical Liothyronine Sodium
Parameter Specification
Active Compound Liothyronine Sodium (T3)
CAS Number 55-06-1
Molecular Formula C₁₅H₁₁I₃NNaO₄
Molecular Weight 672.96 g/mol
Manufacturer Driada Medical
Storage Requirements Room temperature, dry conditions
Stability 24 months when stored properly

Research Compliance

This Liothyronine Sodium preparation is manufactured by Driada Medical exclusively for in-vitro laboratory research purposes. The compound is not intended for human consumption, clinical application, or any form of diagnostic use. Research institutions must ensure proper laboratory protocols, appropriate safety measures, and compliance with relevant research guidelines when handling this material. All studies should be conducted under appropriate ethical oversight and institutional review board approval where applicable. Researchers must maintain detailed documentation of experimental protocols and results in accordance with good laboratory practices.

Related